Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Alternative donor HSCT in refractory acquired aplastic anemia: The time has come

    Journal Title:  Pediatr Transplant Primary Author:  Handgretinger R Author(s):  ...

    Research Article last updated 07/31/2012 - 2:33pm.

  2. A promising new treatment for refractory aplastic anemia

    Journal Title:  N Engl J Med Primary Author:  Metcalf D Author(s):  Metcalf D...

    Research Article last updated 07/31/2012 - 2:23pm.

  3. HYPOMETHYLATING AGENTS (HMA) TREATMENT FOR MYELODYSPLASTIC SYNDROMES: ALTERNATIVES IN THE FRONTLINE AND RELAPSE SETTINGS

    ... an increasing focus on studying treatments for patients refractory to HMA treatment. ...

    Research Article last updated 07/18/2017 - 1:15pm.

  4. Britta Will, PhD

    ... and improvements in overall survival, relapse and refractory disease continue to occur in some patients. Recent findings ...

    Grant Recipient last updated 01/12/2018 - 9:48am.

  5. Study of aplastic anemia med shows significant results

    ... efficacy. In patients with aplastic anemia that was refractory to immunosuppression, eltrombopag, a synthetic ...

    Article last updated 04/24/2017 - 7:14am.

  6. Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

    ... and cytarabine in pediatric patients with relapsed or refractory hematologic malignancies included acute myeloid leukemia (AML), ... with fludarabine and cytarabine in patients with relapsed or refractory hematologic malignancies ...

    Clinical Trial last updated 04/28/2016 - 9:48am.

  7. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... Patients with relapsed or refractory SAA or very SAA defined: Bone marrow (< 25% ... Patients with inherited disease will be characterized as refractory and do not require immunosuppressive first. Age 0- upper ...

    Clinical Trial last updated 06/06/2016 - 2:42pm.

  8. 8-Chloro-Adenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... (relapsed) or has not responded to previous treatment ( refractory ). Drugs used in chemotherapy , such as ...

    Clinical Trial last updated 05/23/2016 - 3:25pm.

  9. Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

    ... the use of IRX5183 in 1) patients with relapsed and/or refractory AML and 2) patients with high-risk MDS or chronic myelomonocytic ...

    Clinical Trial last updated 04/29/2016 - 10:22am.

  10. ONC201 in Relapsed/Refractory Acute Leukemias and High-risk Myelodysplastic Syndromes (HR-MDS)

    ... of ONC201 that can be given to patients with relapsed or refractory AML, ALL, or MDS. The goal of Phase II of this study is to ...

    Clinical Trial last updated 04/29/2016 - 10:14am.